Operating Income: The income after operating expenses.
OnKure Therapeutics, Inc. (OKUR) had Operating Income of $-15.50M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-14.70M |
|
-- |
|
-- |
|
$15.50M |
|
|
Operating Income |
$-15.50M |
$0.80M |
|
$-14.70M |
|
$-14.70M |
|
$-14.70M |
|
$-14.70M |
|
$-14.70M |
|
$-14.70M |
|
$-15.50M |
|
$-15.30M |
|
13.53M |
|
13.53M |
|
$-1.09 |
|
$-1.09 |
|
| Balance Sheet Financials | |
$71.53M |
|
$0.72M |
|
$1.31M |
|
$72.83M |
|
$6.25M |
|
-- |
|
$0.16M |
|
$6.41M |
|
$66.43M |
|
$66.43M |
|
$66.43M |
|
13.55M |
|
| Cash Flow Statement Financials | |
$-40.32M |
|
$-0.04M |
|
$-0.08M |
|
$110.76M |
|
$70.33M |
|
$-40.43M |
|
$8.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-40.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.13% |
|
-22.13% |
|
-20.18% |
|
-22.13% |
|
$4.90 |
|
$-2.98 |
|
$-2.98 |
|